Nebulized Hypertonic Saline for Inpatient Use in COPD
Status:
Completed
Trial end date:
2017-01-30
Target enrollment:
Participant gender:
Summary
A comparison of albuterol treatments using hypertonic saline (3%) versus standard saline
(0.9%) in patients with admitted patients COPD in regard to Modified Borg Dyspnea scale
scores after 4 treatments within 24 hours.